Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.58M Sell
42,216
-930
-2% -$232K 0.1% 95
2025
Q4
$10.4M Sell
43,146
-502
-1% -$128K 0.1% 95
2025
Q3
$11.9M Sell
43,648
-101
-0.2% -$27.6K 0.12% 86
2025
Q2
$11.4M Buy
43,749
+288
+0.7% +$68.7K 0.15% 65
2025
Q1
$9.71M Sell
43,461
-106
-0.2% -$24.7K 0.13% 70
2024
Q4
$9.86M Sell
43,567
-292
-0.7% -$70.3K 0.13% 69
2024
Q3
$10.6M Buy
43,859
+36
+0.1% +$8.04K 0.15% 71
2024
Q2
$8.46M Buy
43,823
+947
+2% +$192K 0.13% 69
2024
Q1
$8.5M Buy
+42,876
New +$7.86M 0.13% 67

Other funds holding RMD

ABN AMRO Bank's RMD Position: Q1 2026 in Review

ABN AMRO Bank reduced its ResMed (RMD) stake by 2.2% in Q1 2026, selling an estimated $232K and leaving 42,216 shares worth $9.58M. The position accounts for 0.1% of the portfolio, ranked #95.

ABN AMRO Bank first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $11.9M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • ABN AMRO Bank held 42,216 shares of ResMed worth $9.58M as of Q1 2026.
  • ABN AMRO Bank sold 930 ResMed shares in Q1 2026, an estimated $232K.
  • ResMed made up 0.1% of ABN AMRO Bank's portfolio in Q1 2026, its #95 holding.
  • ABN AMRO Bank first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • ABN AMRO Bank's ResMed position peaked at $11.9M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.